These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3395834)

  • 21. Parietal cell vagotomy. II. The first decade--clinical considerations.
    Hershlag A; Argov S
    Curr Surg; 1983; 40(2):93-104. PubMed ID: 6342979
    [No Abstract]   [Full Text] [Related]  

  • 22. Parietal cell vagotomy for duodenal and pyloric ulcers. I. Clinical factors leading to failure of the operation.
    Poppen B; Delin A
    Am J Surg; 1981 Mar; 141(3):323-9. PubMed ID: 7212178
    [No Abstract]   [Full Text] [Related]  

  • 23. Parietal cell vagotomy and truncal vagotomy in elective duodenal ulcer surgery--results after six to twelve years.
    Elfberg BA; Nilsson F; Selking O
    Ups J Med Sci; 1989; 94(2):129-36. PubMed ID: 2763389
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parietal cell vagotomy.
    Johnston D
    Br J Surg; 1988 Mar; 75(3):290-1. PubMed ID: 3349344
    [No Abstract]   [Full Text] [Related]  

  • 25. Proximal gastric vagotomy: follow-up at 10-20 years.
    Johnston GW; Spencer EF; Wilkinson AJ; Kennedy TL
    Br J Surg; 1991 Jan; 78(1):20-3. PubMed ID: 1998856
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proximal gastric vagotomy versus long-term maintenance treatment with cimetidine for chronic duodenal ulcer: a prospective randomised trial.
    Gear MW
    Br Med J (Clin Res Ed); 1983 Jan; 286(6359):98-9. PubMed ID: 6401510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ulcer recurrence after fundus vagotomy for duodenal ulcer. Incidence. Epidemiology].
    Rongère C; de Mestier P; Martin P; Mignon M; Edelmann G
    Ann Chir; 1985 May; 39(4):233-42. PubMed ID: 4026157
    [No Abstract]   [Full Text] [Related]  

  • 28. Proximal gastric vagotomy for duodenal ulcer disease.
    Malangoni MA; Mullins RJ
    South Med J; 1989 Jun; 82(6):733-5. PubMed ID: 2660290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antrectomy and gastroduodenostomy with or without vagotomy in peptic ulcer disease. A prospective study with a 5-year follow-up.
    Rehnberg O
    Acta Chir Scand Suppl; 1983; 515():1-63. PubMed ID: 6579806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Highly selective vagotomy with duodenal dilatation in patients with duodenal ulceration and gastric outlet obstruction.
    Pollard SG; Friend PJ; Dunn DC; Hunter JO
    Br J Surg; 1990 Dec; 77(12):1365-6. PubMed ID: 2276020
    [No Abstract]   [Full Text] [Related]  

  • 31. [Characteristics and factors predicting ulcer recurrence after supraselective vagotomy for duodenal ulcer. Apropos of 95 S.S.V. followed for more than 5 years].
    Saubier EC; Gouillat C
    Chirurgie; 1983; 109(1):31-8. PubMed ID: 6872655
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of parietal cell vagotomy on gastric emptying in duodenal ulcer disease.
    Horton JW; McClelland RN; Weger RV
    Am J Surg; 1982 Jan; 143(1):86-9. PubMed ID: 7053660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ultrastructural study of parietal cells before and after parietal cell vagotomy in patients with duodenal ulcer.
    Romeo G; Sanfilippo G; Basile F; Catania G; Iannello A; Carnazza ML
    Surg Gynecol Obstet; 1981 Jul; 153(1):61-4. PubMed ID: 7244976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastric outlet obstruction after parietal cell vagotomy with omentopexy for perforated duodenal ulcer.
    Ayalon A; Charuzi I; Berlatzky Y; Krausz MM
    Isr J Med Sci; 1980 Dec; 16(12):819-20. PubMed ID: 7451109
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Kaplan and Meier and the Nelson estimate for the probability of ulcer recurrence 10 and 15 years after parietal cell vagotomy.
    Meisner S; Jørgensen LN; Jensen HE
    Ann Surg; 1988 Jan; 207(1):1-3. PubMed ID: 3337557
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is antral gastrin important in the resistance of duodenal ulcers to H2 receptor antagonists or in recurrent ulceration after highly selective vagotomy?
    Primrose JN; Naik KS; Blackett RL; King RF; Holmfield JH; Lagopolous M; Johnston D
    Gut; 1990 Jul; 31(7):763-6. PubMed ID: 1973394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Parietal cell vagotomy in duodenal ulcer. Results in 119 patients 1-9 year after operation].
    Schulze S; Poulsen PE; Christiansen J
    Ugeskr Laeger; 1982 Mar; 144(10):710-3. PubMed ID: 7101494
    [No Abstract]   [Full Text] [Related]  

  • 38. [Proximal gastric vagotomy for duodenal ulcer. Experience with 56 patients (author's transl)].
    Jara L; Huenchullán I; Arredondo G; Fernández E
    Rev Med Chil; 1981 Nov; 109(11):1076-8. PubMed ID: 7345521
    [No Abstract]   [Full Text] [Related]  

  • 39. Leucomethylene blue staining during vagotomy.
    Wille-Jørgensen P; Jensen HE
    Br J Surg; 1981 Feb; 68(2):81-2. PubMed ID: 6161670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Long-term results of selective vagotomy plus antrectomy in treatment of duodenal ulcer].
    Wu X; Li N; Han J; Liu F; Xu Z; Li J
    Zhonghua Wai Ke Za Zhi; 2002 Nov; 40(11):834-7. PubMed ID: 12487857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.